AZTA
HoldHot AirAzenta, Inc. · Healthcare · United States · $1.4B · Avg Vol: $26M/d
Hot Air: Rising on momentum alone: weak business, rich price.
ABOUT AZENTA, INC.
Read
Azenta, Inc. provides life sciences solutions, including automated sample management systems, consumables, and genomics services to pharmaceutical, biotech, and academic researchers. A leader in its field, its integrated solutions, proprietary automation, and global infrastructure improve research efficiency and reliability, creating a competitive advantage. Azenta is a pure-play life sciences technology company, well-positioned for growth in genomics and sample preservation.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 555.5M | 551.5M | 573.4M | 593.8M | 2.2% | 613.8M | 615.1M | 641.3M | 3.9% |
| EPS | 28.48 | -0.22 | -3.60 | -1.30 | — | -2.46 | — | — | — |
| Shares | 75.0M | 57.8M | 45.6M | 45.9M | -38.9% | 43.8M | — | — | — |
| Debt | 49.2M | 60.4M | 56.7M | 51.2M | 1.3% | 54.0M | — | — | — |
| Equity | 3.4B | 2.5B | 1.8B | 1.7B | -19.9% | — | — | — | — |
| Op CF | -466.0M | 5.8M | 49.7M | 72.2M | 251.7% | 38.0M | — | — | — |
| Inv CF | 1.5B | 431.4M | 224.7M | -90.5M | — | — | — | — | — |
| Fin CF | -62.8M | -840.5M | -659.2M | -9.6M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of AZTA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| AZTA | Azenta, Inc.(you) | $1.4B | 46 | Hold |
| BLFS | BioLife Solutions, Inc. | $1.8B | 50 | Hold |
| LMAT | LeMaitre Vascular, Inc. | $1.8B | 53 | Hold |
| STAA | STAAR Surgical Company | $1.1B | 57 | Hold |
| XRAY | DENTSPLY SIRONA Inc. | $2.2B | 58 | Hold |
| KMTS | Kestra Medical Technologies, Ltd. | $1.5B | 26 | Sell |
| ANGO | AngioDynamics, Inc. | $655M | 52 | Hold |
| WRBY | Warby Parker Inc. | $3.1B | 34 | Sell |
| ATRC | AtriCure, Inc. | $2.5B | 64 | Hold |
| MMED | MiniMed Group, Inc. | $5.7B | 40 | Hold |
Peer medians: ROE -31.0% · P/E 25.1x · Gross margin 58.3%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.